Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Metabolomics of muscle in insulin sensitive and resistant obese indivduals. (Study ST000841)

C18 POSITIVE ION MODE/Triple TOF (Analysis AN001352)

Metabolite	Structure	F1	F2	F3	F4
CE(18:3); [M+NH4]+@10.54	ME222976	0.90	1.27	0.44	2.92
SM 42:5; [M]+@6.53	ME223096	0.71	0.83	1.07	2.67
PC 36:6; [M+H]+@5.35	ME223037	0.52	1.45	1.25	0.20
CE(20:3); [M+NH4]+@10.82	ME222977	0.68	1.01	1.35	0.87
lysoPC 20:1; [M+H]+@2.51	ME223180	0.48	0.98	1.64	0.54
CE(16:0); [M+NH4]+@11.03	ME222971	0.69	1.71	0.55	1.56
TG 54:7; [M+NH4]+@9.92	ME223145	0.63	1.68	0.60	1.74
DG 30:2; [M+NH4]+@6.46	ME222985	1.62	0.86	0.41	1.40
lysoPC 22:0; [M+H]+@4.21	ME223184	1.22	1.22	0.53	1.23
lysoPC 17:1; [M+H]+@1.42	ME223173	1.10	1.13	0.64	1.67
TG 40:0; [M+NH4]+@9.50	ME223101	1.24	0.96	0.68	1.52
TG 42:0; [M+NH4]+@9.79	ME223102	1.39	0.80	0.69	1.46
PC 32:3; [M+H]+@5.09	ME223021	0.82	1.18	0.98	1.19
TG 58:9; [M+NH4]+@10.15	ME223167	0.74	1.23	1.00	1.26
TG 52:6; [M+NH4]+@9.85	ME223131	0.74	1.31	0.92	1.31
TG 54:8; [M+NH4]+@9.73	ME223146	0.63	1.39	0.93	1.43
TG 58:10; [M+NH4]+@9.98	ME223158	0.65	1.33	0.98	1.36
TG 56:9; [M+NH4]+@9.85	ME223156	0.66	1.36	0.96	1.29
TG 58:11; [M+NH4]+@9.80	ME223159	0.61	1.38	0.98	1.33
lysoPC 18:3; [M+H]+@1.06	ME223177	0.78	1.14	1.00	1.45
TG 50:4; [M+NH4]+@9.97	ME223120	0.76	1.23	0.94	1.43
TG 56:8; [M+NH4]+@10.05	ME223155	0.78	1.25	0.91	1.42
TG 50:5; [M+NH4]+@9.77	ME223121	0.72	1.36	0.86	1.47
TG 52:5; [M+NH4]+@10.03	ME223130	0.81	1.25	0.85	1.53
TG 53:1; [M+NH4]+@10.98	ME223133	0.97	1.57	0.51	1.03
PC 33:1; [M+H]+@6.36	ME223022	0.84	1.34	0.82	1.16
TG 48:3; [M+NH4]+@9.91	ME223112	0.85	1.30	0.82	1.28
DG 38:2; [M+NH4]+@8.58	ME223005	0.86	1.45	0.67	1.30
TG 44:2; [M+NH4]+@9.56	ME223105	0.88	1.36	0.72	1.34
TG 58:5; [M+NH4]+@10.85	ME223163	0.89	1.39	0.69	1.34
TG 51:3; [M+NH4]+@10.36	ME223124	0.84	1.57	0.60	1.23
TG 58:8; [M+NH4]+@10.29	ME223166	0.77	1.52	0.73	1.17
SM 43:1; [M]+@8.34	ME223097	0.82	1.46	0.72	1.22
DG 34:2; [M+NH4]+@7.61	ME222993	0.90	1.44	0.67	1.19
DG 36:4; [M+NH4]+@7.38	ME223002	0.87	1.46	0.68	1.18
TG 54:1; [M+NH4]+@11.11	ME223139	1.06	1.04	0.77	1.64
TG 57:7; [M+NH4]+@10.39	ME223157	0.96	1.00	0.88	1.69
PE 37:4; [M+H]+@6.64	ME223059	0.94	1.08	0.83	1.69
TG 52:3; [M+NH4]+@10.43	ME223128	0.94	1.05	0.86	1.69
TG 53:2; [M+NH4]+@10.79	ME223134	0.96	1.13	0.81	1.52
TG 56:2; [M+NH4]+@11.13	ME223149	1.00	1.12	0.78	1.55
TG 54:3; [M+NH4]+@10.70	ME223141	0.92	1.11	0.87	1.52
TG 54:4; [M+NH4]+@10.48	ME223142	0.89	1.13	0.87	1.58
TG 51:2; [M+NH4]+@10.55	ME223123	0.99	1.07	0.84	1.48
TG 46:2; [M+NH4]+@9.86	ME223108	1.01	1.11	0.79	1.43
TG 54:2; [M+NH4]+@10.90	ME223140	1.03	1.09	0.80	1.41
TG 53:3; [M+NH4]+@10.59	ME223135	0.92	1.16	0.84	1.46
TG 58:3; [M+NH4]+@11.16	ME223161	0.93	1.09	0.90	1.41
PC 32:2; [M+H]+@5.50	ME223020	0.94	0.99	0.94	1.55
TG 52:4; [M+NH4]+@10.23	ME223129	0.92	1.02	0.94	1.57
DG 33:1; [M+NH4]+@7.76	ME222991	0.99	1.00	0.88	1.53
TG 52:2; [M+NH4]+@10.63	ME223127	0.99	1.00	0.89	1.58
PE 32:2; [M+H]+@5.73	ME223051	0.81	1.06	1.03	1.51
TG 54:5; [M+NH4]+@10.29	ME223143	0.84	1.07	0.98	1.53
PC 34:1; [M+H]+@6.61	ME223024	0.89	0.99	1.00	1.51
TG 50:2; [M+NH4]+@10.39	ME223118	0.93	1.01	0.95	1.48
PE 35:2; [M+H]+@6.68	ME223054	0.88	1.05	0.97	1.50
PE 36:4; [M+H]+@6.35	ME223058	0.90	1.03	0.97	1.48
PC 34:4; [M+H]+@5.40	ME223027	0.87	1.00	0.99	1.63
TG 53:4; [M+NH4]+@10.40	ME223136	0.85	1.12	0.90	1.64
TG 53:5; [M+NH4]+@10.20	ME223137	0.82	1.11	0.94	1.60
lysoPE 20:4; [M+H]+@1.26	ME223189	1.09	0.92	0.93	1.27
DG 40:6; [M+NH4]+@7.77	ME223013	1.10	0.89	0.94	1.24
TG 50:0; [M+NH4]+@10.84	ME223116	1.10	0.89	0.95	1.21
lysoPE 16:0; [M+H]+@1.68	ME223186	1.18	0.86	0.88	1.32
CE(18:0); [M+NH4]+@11.42	ME222973	1.11	0.88	0.92	1.34
DG 34:0; [M+NH4]+@8.42	ME222992	1.11	0.93	0.87	1.33
TG 52:0; [M+NH4]+@11.09	ME223125	1.11	0.91	0.89	1.35
TG 49:0; [M+NH4]+@10.72	ME223113	1.11	0.77	0.96	1.59
DG 31:0; [M+NH4]+@7.63	ME222986	1.03	0.86	0.99	1.49
TG 48:0; [M+NH4]+@10.60	ME223109	1.08	0.80	1.02	1.37
lysoPC 20:4; [M+H]+@1.30	ME223182	1.24	0.78	0.84	1.48
TG 46:0; [M+NH4]+@10.35	ME223106	1.20	0.86	0.83	1.40
TG 44:1; [M+NH4]+@9.83	ME223104	1.09	0.98	0.83	1.44
TG 51:1; [M+NH4]+@10.75	ME223122	1.12	0.91	0.85	1.48
TG 52:1; [M+NH4]+@10.85	ME223126	1.10	0.91	0.87	1.51
DG 30:0; [M+NH4]+@7.40	ME222983	1.15	0.88	0.83	1.61
TG 48:1; [M+NH4]+@10.36	ME223110	1.08	0.92	0.85	1.62
TG 50:1; [M+NH4]+@10.59	ME223117	1.05	0.90	0.90	1.62
PC 30:0; [M+H]+@5.87	ME223017	0.93	0.83	1.12	1.47
PC 35:4; [M+H]+@5.78	ME223030	0.89	0.89	1.12	1.38
plasmenyl-PE 36:5; [M+H]+@6.30	ME223196	0.87	0.83	1.23	1.23
SM 41:5; [M]+@6.60	ME223092	0.96	0.80	1.17	1.26
DG 35:3; [M+NH4]+@7.51	ME222997	1.15	1.09	0.73	1.18
TG 46:1; [M+NH4]+@10.11	ME223107	1.13	1.05	0.78	1.20
DG 36:1; [M+NH4]+@8.50	ME222999	1.08	1.08	0.81	1.18
DG 40:7; [M+NH4]+@7.60	ME223014	1.09	1.06	0.81	1.21
TG 49:2; [M+NH4]+@10.29	ME223115	1.00	1.09	0.85	1.34
DG 32:1; [M+NH4]+@7.50	ME222988	1.07	1.08	0.80	1.26
DG 35:1; [M+NH4]+@8.25	ME222995	1.06	1.04	0.84	1.31
TG 42:1; [M+NH4]+@9.53	ME223103	1.05	1.18	0.73	1.29
DG 34:3; [M+NH4]+@7.22	ME222994	1.00	1.19	0.78	1.23
DG 32:2; [M+NH4]+@7.09	ME222989	0.99	1.14	0.84	1.24
TG 56:3; [M+NH4]+@10.93	ME223150	1.00	1.14	0.81	1.30
PE 34:2; [M+H]+@6.38	ME223053	0.84	1.15	0.94	1.38
TG 56:7; [M+NH4]+@10.24	ME223154	0.85	1.13	0.95	1.40
PC 36:1; [M+H]+@7.22	ME223032	0.85	1.06	1.03	1.34
TG 56:6; [M+NH4]+@10.43	ME223153	0.87	1.10	0.97	1.33
SM 40:1; [M]+@7.65	ME223087	0.89	1.07	0.97	1.37
SM 41:2; [M]+@7.43	ME223091	0.89	1.06	0.98	1.36
plasmenyl-PE 32:1; [M+H]+@6.57	ME223190	0.97	0.99	0.97	1.30
TG 48:2; [M+NH4]+@10.15	ME223111	0.98	1.01	0.95	1.25
TG 56:1; [M+NH4]+@11.35	ME223148	0.98	1.01	0.94	1.29
TG 56:5; [M+NH4]+@10.60	ME223152	0.97	1.02	0.95	1.28
SM 32:1; [M]+@5.08	ME223067	0.97	1.03	0.93	1.34
SM 38:2; [M]+@6.66	ME223083	0.95	1.03	0.95	1.34
PC 33:2; [M+H]+@5.85	ME223023	0.94	1.03	0.97	1.30
PC 40:4; [M+H]+@7.27	ME223043	0.91	1.06	0.97	1.30
SM 40:2; [M]+@7.20	ME223088	0.90	1.11	0.94	1.26
SM 37:1; [M]+@6.70	ME223079	0.95	1.06	0.95	1.23
PC 38:2; [M+H]+@7.31	ME223038	0.92	1.05	0.99	1.23
SM 33:1; [M]+@5.44	ME223070	0.93	1.05	0.97	1.25
PC 19:1; [M+H]+@1.78	ME223016	0.99	0.90	1.03	1.31
PC 38:5; [M+H]+@6.30	ME223041	0.89	0.98	1.03	1.40
plasmenyl-PE 36:1; [M+H]+@7.68	ME223193	0.90	0.97	1.03	1.43
PE 34:1; [M+H]+@6.81	ME223052	0.94	0.95	1.03	1.32
PE 36:1; [M+H]+@7.39	ME223056	0.92	0.97	1.04	1.33
TG 58:6; [M+NH4]+@10.65	ME223164	0.93	1.00	1.00	1.36
PC 38:4; [M+H]+@6.75	ME223040	0.92	1.00	1.01	1.33
SM 42:2; [M]+@7.70	ME223094	0.90	1.01	1.01	1.35
SM 40:0; [M]+@7.89	ME223086	0.98	0.98	0.93	1.47
PC 38:6; [M+H]+@6.06	ME223042	0.98	0.97	0.96	1.37
SM 41:1; [M]+@7.90	ME223090	0.97	1.00	0.94	1.40
PC 34:2; [M+H]+@6.16	ME223025	0.96	0.94	1.00	1.39
PE 36:2; [M+H]+@6.96	ME223057	0.98	0.95	0.96	1.42
CE(20:4); [M+NH4]+@10.65	ME222978	0.87	0.93	1.16	1.14
PC 40:5; [M+H]+@6.82	ME223044	0.90	0.99	1.08	1.13
PC 40:8; [M+H]+@5.75	ME223046	0.85	1.07	1.04	1.24
SM 42:4; [M]+@6.86	ME223095	0.81	1.10	1.04	1.25
PC 32:0; [M+H]+@6.48	ME223019	0.91	0.94	1.09	1.28
plasmenyl-PE 34:2; [M+H]+@6.67	ME223192	0.90	1.01	1.04	1.22
PC 36:5; [M+H]+@5.70	ME223036	0.88	0.98	1.08	1.26
TG 58:2; [M+NH4]+@11.36	ME223160	0.87	1.00	1.07	1.26
DG 40:5; [M+NH4]+@8.08	ME223012	1.12	0.95	0.91	1.05
lysoPE 18:0; [M+H]+@2.48	ME223187	1.08	0.97	0.95	1.02
PE 21:4; [M+H]+@1.33	ME223049	1.06	0.97	0.97	1.02
DG 36:0; [M+NH4]+@8.88	ME222998	1.01	0.95	1.04	0.98
PE 23:4; [M+H]+@1.89	ME223050	1.08	0.92	1.01	0.94
TG 58:7; [M+NH4]+@10.49	ME223165	0.91	1.07	0.99	1.18
PC 38:3; [M+H]+@7.00	ME223039	0.90	1.05	1.02	1.13
TG 50:3; [M+NH4]+@10.18	ME223119	0.86	1.07	1.04	1.15
PC 36:3; [M+H]+@6.31	ME223034	0.90	1.13	0.94	1.18
SM 34:2; [M]+@5.27	ME223074	0.90	1.12	0.97	1.09
lysoPC 18:2; [M+H]+@1.25	ME223176	1.06	0.95	0.95	1.16
SM 37:2; [M]+@6.33	ME223080	1.02	0.94	0.98	1.21
plasmenyl-PE 36:2; [M+H]+@7.26	ME223194	0.98	1.02	0.96	1.20
SM 36:1; [M]+@6.43	ME223077	0.99	0.99	0.98	1.19
SM 39:2; [M]+@7.01	ME223085	0.97	0.97	1.01	1.22
TG 58:4; [M+NH4]+@10.99	ME223162	0.94	0.97	1.04	1.22
TG 56:4; [M+NH4]+@10.76	ME223151	1.01	1.03	0.91	1.23
DG 38:6; [M+NH4]+@7.38	ME223009	0.99	1.08	0.91	1.14
SM 38:1; [M]+@7.12	ME223082	0.97	1.07	0.94	1.13
SM 30:1; [M]+@4.29	ME223065	1.01	1.04	0.92	1.14
PE 40:1; [M+H]+@8.37	ME223061	1.02	1.05	0.90	1.17
SM 34:0; [M]+@6.04	ME223072	1.01	1.05	0.90	1.18
PE 38:4; [M+H]+@6.98	ME223060	0.98	1.05	0.97	1.03
SM 36:0; [M]+@6.74	ME223076	0.99	0.98	1.01	1.09
TG 62:1; [M+NH4]+@12.22	ME223168	0.96	0.97	1.05	1.09
DG 38:1; [M+NH4]+@8.95	ME223004	1.02	1.01	0.96	1.08
plasmenyl-PE 38:3; [M+H]+@7.49	ME223199	1.04	0.99	0.94	1.10
SM 43:2; [M]+@7.86	ME223098	1.00	1.00	0.96	1.15
DG 38:5; [M+NH4]+@7.69	ME223008	1.00	1.03	0.95	1.11
lysoPE 18:2; [M+H]+@1.32	ME223188	0.98	1.01	0.98	1.11
SM 38:0; [M]+@6.20	ME223081	1.23	0.74	1.00	1.02
DG 38:7; [M+NH4]+@6.93	ME223010	1.16	0.65	1.11	1.17
DG 32:0; [M+NH4]+@7.90	ME222987	1.07	0.87	1.01	1.14
DG 33:0; [M+NH4]+@8.12	ME222990	1.13	0.77	1.04	1.20
DG 40:4; [M+NH4]+@8.49	ME223011	1.46	0.76	0.73	1.09
PC 35:3; [M+H]+@6.01	ME223029	1.25	0.96	0.77	1.11
TG 54:0; [M+NH4]+@11.33	ME223138	1.27	0.91	0.80	1.05
CE(17:1); [M+NH4]+@10.93	ME222972	1.18	1.09	0.87	0.41
lysoPC 20:3; [M+H]+@1.43	ME223181	1.33	0.89	0.86	0.57
PC 35:5; [M+H]+@5.47	ME223031	1.46	0.84	0.77	0.64
lysoPC 15:0; [M+H]+@1.24	ME223170	0.88	1.11	1.15	0.40
DG 35:2; [M+NH4]+@7.87	ME222996	0.95	1.12	0.97	0.84
plasmenyl-PE 38:1; [M+H]+@8.18	ME223197	0.95	1.10	0.99	0.88
PC 35:2; [M+H]+@6.45	ME223028	0.97	1.01	1.04	0.94
SM 36:2; [M]+@5.94	ME223078	0.95	1.03	1.03	0.98
DG 36:2; [M+NH4]+@8.07	ME223000	0.94	1.08	1.01	0.92
PE 36:0; [M+H]+@7.82	ME223055	0.99	1.05	0.99	0.93
DG 36:3; [M+NH4]+@7.71	ME223001	0.86	1.19	0.99	0.93
SM 40:4; [M]+@6.30	ME223089	0.89	1.18	0.96	0.93
SM 33:0; [M]+@5.73	ME223069	1.02	1.12	0.88	0.99
DG 40:8; [M+NH4]+@7.18	ME223015	0.96	1.15	0.92	0.91
SM 39:1; [M]+@7.40	ME223084	0.99	1.14	0.90	0.95
plasmenyl-PE 36:4; [M+H]+@6.63	ME223195	1.00	0.89	1.11	0.93
TG 56:0; [M+NH4]+@11.59	ME223147	0.98	0.89	1.13	0.95
plasmenyl-PE 38:4; [M+H]+@7.25	ME223200	0.98	0.93	1.11	0.89
plasmenyl-PE 40:4; [M+H]+@7.67	ME223201	0.95	0.95	1.13	0.85
SM 31:1; [M]+@4.74	ME223066	0.99	0.94	1.11	0.82
SM 42:1; [M]+@8.16	ME223093	0.87	1.00	1.16	0.87
SM 44:2; [M]+@8.23	ME223100	0.86	1.08	1.09	0.89
CE(22:5); [M+NH4]+@10.75	ME222981	0.96	0.99	1.08	0.83
lysoPC 14:0; [M+H]+@1.00	ME223169	0.93	1.05	1.07	0.81
PC 36:2; [M+H]+@6.81	ME223033	0.87	1.05	1.14	0.77
SM 34:1; [M]+@5.75	ME223073	0.92	0.98	1.15	0.78
DG 38:4; [M+NH4]+@8.04	ME223007	1.01	0.92	1.15	0.61
lysoPC 16:0; [M+H]+@1.55	ME223171	1.07	0.91	1.11	0.61
lysoPC 18:1; [M+H]+@1.65	ME223175	1.03	1.04	1.05	0.53
SM 44:1; [M]+@8.66	ME223099	0.95	1.09	1.07	0.55
lysoPC 20:5; [M+H]+@1.02	ME223183	1.18	0.90	0.95	0.80
lysoPC 20:0; [M+H]+@3.25	ME223179	1.11	1.07	0.91	0.68
SM 35:2; [M]+@5.65	ME223075	1.09	1.03	0.96	0.67
lysoPC 18:0; [M+H]+@2.31	ME223174	0.97	1.11	1.00	0.72
lysoPC 19:0; [M+H]+@2.81	ME223178	1.06	0.97	1.02	0.80
PE 19:2; [M+H]+@1.39	ME223048	1.04	1.06	0.95	0.80
PC 42:5; [M+H]+@7.46	ME223047	1.10	1.19	0.75	0.94
CE(22:6); [M+NH4]+@10.54	ME222982	0.90	1.37	0.84	0.70
DG 38:3; [M+NH4]+@8.35	ME223006	1.00	1.34	0.76	0.70
PC 34:3; [M+H]+@5.73	ME223026	0.84	1.39	0.84	0.90
TG 53:0; [M+NH4]+@11.20	ME223132	0.93	1.31	0.81	0.90
plasmenyl-PE 38:2; [M+H]+@7.82	ME223198	0.96	1.38	0.73	0.88
SM 32:2; [M]+@4.48	ME223068	1.00	1.32	0.75	0.83
DG 36:5; [M+NH4]+@6.99	ME223003	0.80	1.38	0.95	0.60
CE(18:1); [M+NH4]+@11.05	ME222974	0.73	1.27	1.08	0.78
CE(18:2); [M+NH4]+@10.79	ME222975	0.67	1.28	1.10	0.90
SM 33:2; [M]+@4.94	ME223071	1.44	0.52	0.74	2.07
CE(20:5); [M+NH4]+@10.45	ME222979	0.89	0.60	1.29	1.76
DG 30:1; [M+NH4]+@6.93	ME222984	1.03	0.99	0.75	2.02
PE 40:4; [M+H]+@7.38	ME223062	1.05	0.79	0.92	1.97
TG 49:1; [M+NH4]+@10.51	ME223114	1.05	0.87	0.87	1.91
PE 40:6; [M+H]+@6.88	ME223064	0.74	1.06	1.05	1.68
PC 30:1; [M+H]+@5.37	ME223018	0.84	0.93	1.04	1.84
PE 40:5; [M+H]+@7.24	ME223063	0.89	0.90	1.00	1.88
PC 36:4; [M+H]+@5.97	ME223035	0.93	0.87	1.01	1.77
plasmenyl-PE 34:1; [M+H]+@7.11	ME223191	0.87	0.94	1.02	1.74
PC 40:6; [M+H]+@6.65	ME223045	0.83	0.95	0.96	2.13
TG 54:6; [M+NH4]+@10.09	ME223144	0.76	1.11	0.93	1.93
lysoPC 22:6; [M+H]+@1.18	ME223185	1.32	1.59	0.30	0.33
CE(22:4); [M+NH4]+@10.93	ME222980	1.55	0.39	1.22	0.00
lysoPC 16:1; [M+H]+@1.15	ME223172	1.93	0.73	0.42	0.49

Factors:

F1	Subject group:HIGH-FA
F2	Subject group:LOW-FA
F3	Subject group:MID-FA
F4	Subject group:N/A

Data matrix